B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CCNT2

MOLECULAR TARGET

cyclin T2

UniProt: O60583NCBI Gene: 9051 compounds

CCNT2 (cyclin T2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CCNT2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1kenpaullone0.691

About CCNT2 as a Drug Target

CCNT2 (cyclin T2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented CCNT2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CCNT2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.